Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar I Disorder Without Psychotic Symptoms”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Large-scale testing (Phase 3)Study completedNCT00110461
What this trial is testing

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 296
Testing effectiveness (Phase 2)Study completedNCT00442039
What this trial is testing

Lithium for the Treatment of Pediatric Mania

Who this might be right for
Bipolar I Disorder Without Psychotic Symptoms
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 61
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Large-scale testing (Phase 3)Ended earlyNCT01122927
What this trial is testing

Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.

Who this might be right for
Adolescent SchizophreniaChild or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Otsuka Pharmaceutical Development & Commercialization, Inc. 524